```
REGISTERED COMPANY NUMBER: 01886866 (England and Wales)
REGISTERED CHARITY NUMBER: 291982
```
```
Report of the Trustees and
```
```
Unaudited Financial Statements
```
```
for the Year Ended 31 December 2021
```
```
for
```
```
SYMPOSIUM MAMMOGRAPHICUM
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
```
Contents of the Financial Statements
for the Year Ended 31 December 2021
```
||**`Page`**|
|---|---|
|**`Report of the Trustees`**|`1 to 8`|
|**`Independent Examiner's Report`**|`9`|
|**`Statement of Financial Activities`**|`10`|
|**`Balance Sheet`**|`11 to 12`|
|**`Notes to the Financial Statements`**|`13 to 17`|
|**`Detailed Statement of Financial Activities`**|`18 to 19`|
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
```
ThetrusteeswhoarealsodirectorsofthecharityforthepurposesoftheCompaniesAct2006,present their
reportwiththefinancialstatementsofthecharityfortheyearended31December2021.Thetrustees have
adoptedtheprovisionsofAccountingandReportingbyCharities:StatementofRecommended Practice
applicableto charitiespreparingtheiraccountsin accordancewiththe FinancialReportingStandardapplicable in
the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
```
## **`OBJECTIVES AND ACTIVITIES`**
## **`Objectives and aims`**
```
The charity'sobjectivesand aims are to promoteresearchand to disseminateknowledgeaboutimprovements in
methodsandtechniquesfortheprevention,diagnosisandtreatmentofbreastdisease-cancerand other
disorders.
```
```
Page 1
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
## **`OBJECTIVES AND ACTIVITIES Significant activities`**
## **`Conference`**
```
Thecharity's20thconference(symposium)tookplacebetween7 and10February2021,on-line.Thisevent was
originallyscheduledtobehostedattheHarrogateConferenceCentreinJuly2020.Duetothe government
restrictionsand'lockdowns'imposedduring2020,theeventwaspostponed.TheTrusteesconsideredat length
theoptionssurroundingpostponementandprogressinganonlineevent.Muchoftheplanningtookplace in
2019,supportedbyfurthersignificantworktoadapttheeventtobeaccessed,withparticularreferenceto the
scientific programme, technical exhibition and workshops.
```
```
Theconferenceprogrammeconsistedoftheusualkeynoteaddressesandplenarysessions,alongwith parallel
andprofferedpapersessions,satellitesymposia,workshopsandposters.Opportunitieswereretained for
delegatestoseethelatestdevelopmentsin imaginganddiagnosticproceduresonline.Thecharity,aspartof its
enthusiasmto widen the scopeof the event,continuedto collaboratewith the Associationof BreastClinicians to
helppromotegreaterexchangeofknowledgeanddebatewithintheconference.Theconferencealsohosted a
session run by the Association of Breast Surgery, as part of an established reciprocal arrangement started in 2017.
```
```
The OrganisingCommitteefor the 2021event was chairedby Mrs ClaireBorrelliand vice chair,Dr Sarah Tennant,
bothtrustees.TheCommitteeismadeupoftrusteesaswellasinvitedmembersfromarangeofdisciplines to
complement the core team and enhance the conference programme.
```
```
Overall,theeventprovedtobeverysuccessfulinattractingover650delegates,withagreatdealof positive
feedbackregardingtheonlinedelivery.Delegateswelcomedtheopportunitytoparticipateatatime when
movementandgatheringrestrictionswerein force.Theuseofup-to-datetechnologyhadenabledcolleagues to
interactwithspeakersanddiscusssessiontopics.TheTrusteesareindebtedtothedelegates(andtheir funding
agencies,primarilythe NHS)formakingthe timeto takepartwhenthe healthservicewasunder unprecedented
pressure,andtoalloursponsorsandexhibitors,withoutwhichthestagingofthiseventwouldnothave been
possible.
```
## **`Working with other organisations`**
```
Areciprocalarrangementhostingasessionateachother'seventsisnowestablishedwiththeAssociation of
BreastSurgery(ABS).InMay2019,SymposiumMammographicumaddressedtheABSconferencebyhosting a
parallelsession,andwilldosoagainattheACCLiverpoolon16-17May2022.DuetoCovid-19restrictions, the
ABSeventin2021wasonline,withnoparallelsessions,whichprecludedtheprovisionofabreast radiology
session by the Charity.
```
```
ThecharityembeddeditssupportfortheSocietyofRadiologistsinTraining(SRT)byholdingaseriesof breast
biopsyworkshopsattheirannualconferenceinMay2019inCardiffbuttheCovid-19pandemicledto the
cancellationof their conferencein 2020.However,the charityhad given a Breast2B FellowshipViva workshop at
their 2021 event on the 13-14 June, online.
```
```
SymposiumMammographicumwaslastabletopromoteitsworkattheUKIO(UKImagingand Oncology)
ConferenceinJune2019inLiverpool,atwhichbreastbiopsyworkshopstookplaceovertwodays.The UKIO
extendedtheir generosityby providingexhibitionstand space to the charity.Due to the pandemic,their 2020 and
2021conferencestookplaceonline,and it waslogisticallytoochallengingto run workshops.However,plans are
in to run workshops at their 2022 event at the ACC Liverpool.
```
```
Page 2
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
## **`OBJECTIVES AND ACTIVITIES`**
```
Workalso continuedduring 2021to progressopportunitiesto workwith the Associationof BreastPathology, the
SocietyofRadiographersandorganisersoftheUKInterdisciplinaryBreastCancerSymposium(UKIBCS).The last
organisationhasappointedDrMichaelMichelltobeSymposiumMammographicum'srepresentative,with Dr
VinnicombealreadyontheUKIBCScommittee.Again,relatedtothepandemic,theUKIBCSwasplanningto hold
theirconferenceonlineinJanuary2022atwhichthreelecturesonbreastradiologywereincluded, with
Symposium Mammographicum being formally recognised as a co-sponsor.
```
## **`Volunteers`**
```
ThecharityreceivessupportfromanumberofclinicianswhohavejoinedtheCOC,whoprovide additional
expertisetodevelopthescientificprogrammeforthebiennialconference.Thetrusteesaregratefulforthe time
and dedication that the additional COC members contribute, considerably enriching the conference programmes.
```
## **`ACHIEVEMENT AND PERFORMANCE`**
## **`Charitable activities`**
```
SymposiumMammographicumpromotesanAwardschemeofup to£2,500eachforradiologists, radiographers
orothermembersofthediagnosticbreastteamresidingandworkingintheUnitedKingdom.Thesecan consist
eitherof an EducationalAward- to take up a secondmentat a recognisedcentrein the UK or overseasto study a
particularaspectof breastimagingpractice,ora ResearchAward- toundertakea smallresearchproject related
to breastimaging.The aim of the Awardsis to supportwork which will contributeto improvementin the practice
of breast imaging in the UK.
```
```
Twoawardsforprojectswerefundedinprinciplein2020(deferredto2021andpresentedatthe Symposium
Mammographicum conference).
```
```
- Contrastenhanceddigitalbreasttomosynthesisforthemonitoringofresponsetoneoadjuvant chemotherapy:
preliminary results
```
```
-Aplannedfeasibilityandpilotstudytocomparetwomammographicimagingprotocolsinwomenwith breast
implants.
```
```
The charityalsoprovidesbursariesfor applicantsfromoutsidethe UnitedKingdom,whichaim eitherto facilitate
studybyanobservationalclinicalattachmentinaspecialisttrainingcentreintheUnitedKingdomovera period
ofoneortwoweeks,ortofacilitateattendanceattheSymposiumMammographicumconference.The bursary
schemeis also now open to certaingroupsof peoplewithin the UK to apply for funding to attendthe Symposium
orundertakeaclinicalobservationplacement.Eligiblegroupsincludepublic/patientrepresentatives, and
professionals/studentslookingtoreturntoworkafteracareerbreakorenterthebreastspecialismwithin the
radiography or radiology disciplines.
```
```
Two applicants - both from London -were funded to attend the postponed online conference in February 2021.
```
```
ThetrusteescontinuedtoreviewwaysofpromotingtheAwardandBursaryschemesviaweb-based directories
and on the websitesof supportiveorganisationswhichholdsimilarobjectivesto Symposium Mammographicum.
This has included support from the Higher Education Institutes to help attract radiography students.
```
## **`FINANCIAL REVIEW`**
## **`Principal funding sources`**
```
TheCharity'sprincipalsourcesoffundingaretheregistrationfees,exhibitors'paymentsandsponsorshipof the
symposia.
```
```
Page 3
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
## **`FINANCIAL REVIEW`**
## **`Investment policy and objectives`**
```
The trusteesregularlymonitorthe return on the savingsaccounts,noting the interestrate and potentialaccess to
thereserves,andtakeabalancedapproachgiventhedegreeofriskinarrangingconferences.Following the
trustees'consideredreviewofinvestmentsfrommid-2015tolate2016withguidancefrominvestment advisors
(Sanlam),itwasdecidedtomaintainthecurrentinvestmentprofile,withthecaveatthatregular benchmarking
studiesto compareinterestrateswouldbe undertakento maximisethe return.Such a reviewwas undertaken in
2017fromwhichtrusteessupportedthetransferoffundsfromthethencurrentsavingfacilitiesto different
bankswhichofferedmoreattractiveinterestrates.Thisexercisewascompletedinautumn2017. Performance
wouldbesubjecttoreviewtoensurethecharitywasabletosecureacompetitivereturnon investment,
balanced against risk and accessibility to its reserves. This aspect is considered regularly by the Trustees.
```
## **`Reserves policy`**
```
Thetrusteesareconsciousoftheneedtooptimisethelevelofreservesthecharityhasatitsdisposal. In
consideringthelevel,attentionhasfocusedonthecharity'soperationalneeds,notingthesignificant up-front
costs(andresultantpotentialrisk)in settingup a conference.Regardwasalsopaidtotheperceptionof risk and
effectsthatexternalinfluencescouldhaveonincome(forexample,delegatenumbers,exhibitionsize and
income,venuecosts,economicclimate,reputation),mindfulofthecharity'sobjectsandtheir continuing
relevance.AsummaryreviewoftheReservesPolicywasundertakenin2017andadetailedreview was
completed in 2021 to reflect the change in circumstances arising from the pandemic.
Financial Management Review
Trusteesintroducedamorerobustsetofmeasurestoprovidegreaterclarityonthecharity'sstanding and
financialrobustness,in tandemwith the reservespolicyand strategy.Followingdetaileddiscussionsto consider a
range of options,longerrange forecastingovera two year cyclehas been adoptedto help provideassurance and
highlightany riskswith the projectedand committedexpenditurecounteredby incomelevels,basedon financial
cycleofpastconferences.Aspartofminimisingcoststothecharity,Trusteesagreedtoalternateits quarterly
meetingsbetweenmeetinginpersonandusingonlinevideoconferencing.Trusteesaregratefulto fellow
trustee,MsBurchforprovidinghervaluedsupportbyenhancingthewayfinancialinformationisnow being
presented.
```
```
Page 4
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
## **`FUTURE PLANS`**
## **`Strategic`**
```
ArrangementsfortheScottishExhibitionCentreinGlasgowtohostthe21stSymposium Mammographicum
conferencebetweenthe21stto23June2023weresettled.AnOrganisingCommitteewasestablished in
September 2021, with Dr Sarah Tennant as Chair and Dr Sarah Vinnicombe as Vice-Chair.
```
```
The Committeeis madeup of trusteesas wellas invitedcliniciansfroma rangeof disciplinesto complement the
coreteamand enhancethe conferenceprogramme.The agreementto collaboratewith the Associationof Breast
Clinicianscontinued;theyorganisedtheirownsessionsinparalleltothemainSMprogramme.Inaddition, the
AssociationofBreastSurgeryhasagreedtohostaparallelsessionontopicsoftheirchoicetocomplement the
main themes of the event.
```
## **`Membership / Supporters scheme`**
```
Trusteesreviewedthecurrentarrangementsandconsideredarangeofoptionstoencouragesupport to
SymposiumMammographicuminavarietyofways,changestowhichareexpectedtobeimplemented during
2022.
```
## **`Operational`**
```
TrusteesconsideredandagreedtoappointProfileProductionstoorganisethecharity'sconferencefor 2023,
following the success of the 2021 event, which had incorporated a number of initiatives welcomed by delegates.
```
```
ThecharityappointedSandisonLang&Cotoprovideanindependentexaminationoftheirannualreport and
accounts,witheffectfrom1 January2021.Thisproposalwassupportedat an ExtraordinaryGeneralMeeting on
the 12 December 2019.
```
## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`**
## **`Governing document`**
```
ThecharityisacompanylimitedbyguaranteeasdefinedbytheCompaniesAct2006andisgovernedby its
Memorandum and Articles of Association.
```
```
Page 5
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`**
## **`Organisational structure`**
```
The charity'strusteesmet five times in 2021,to manageits affairs,ensuringthat its work is in line with its mission
andaims,providingastrategicoverviewofthesymposia,financeandbudgetmonitoring, investments,
successionplanning,andreceivingandreviewingofawardandbursaryapplications.Thisincluded additional
meetingstoconsiderissuesconcerningthepandemic.TheboardsetupitsConferenceOrganising Committee
(COC)forthe2023conference,chairedbytrusteeDrSarahTennantwithfellowtrusteeDrSarahVinnicombe as
its Vice-Chair. The expertise of the trustees is augmented on the COC by the appointment of:
```
```
- Ms Charlotte Hawke, Senior Radiographer & Clinical Trainer, Nottingham University Hospitals NHS Trust
```
```
- DrLaraJehanli,RadiologyTrainee,CountessofChesterHospitalandPresidentoftheSocietyofRadiologists in
Training
```
```
- Ms Lyndsay Kinnear, Training and Education Lead, Nightingale Centre, Manchester
```
```
- Miss Michelle Mullan, Consultant Breast Surgeon, North Bristol NHS Trust
```
```
-DrKeerthiniMuthuswamy,RadiologyRegistrar,NationalMedicalDirector'sClinicalFellow,Guy'sand St
Thomas' NHS Foundation Trust, London
```
```
- Dr Marianna Telesca, Consultant Breast Radiologist, Worcestershire Acute Hospitals NHS Trust
```
```
Inaddition,thecharitycontinuedtoworkcloselywiththeAssociationofBreastClinicians,representedby Dr
Cathy Coleman, who is also a trustee of Symposium Mammographicum.
```
```
The Symposiumattractsmembersof the medicaland allied healthprofessionsfromaroundthe UK and also from
aroundtheworld.Manufacturersofmedicalequipmentareinvitedforthepurposeofpresentingtheir own
expertise and information and learning from the like presentation of others.
```
## **`Trustees`**
```
2021sawtwochangestothemembershipoftheTrusteeBoard.InJanuary2021,thetrusteeswerepleased to
appoint:
```
```
- Ms Sarah McKellar, Solicitor and Partner, Norton Rose Fulbright, London and
```
```
- Mr Dominic Ribet, Solicitor and Associate Partner, Cripps Pemberton Cripps LLP, London
```
```
to the Board, formally appointed at the Charity's Annual General Meeting in September 2021.
```
```
MsPatsyWhelehancontinuedin herroleofChairofTrusteesandDrMichaelMichellasthecharity's President.
The TrusteeBoardremainscognisantof the needto reviewsuccessionplanning,discussedat boardmeetings on
aregularbasis.InitialthoughtsaretoestablishafinitenumberofthreeyeartermsofofficeforTrustees which
would be revisited in earnest after the conference cycle has completed in June 2023.
```
```
Page 6
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`**
## **`Risk management`**
```
Thetrusteeshaveadutytoidentifyandreviewtheriskstowhichthecharityisexposedandto ensure
appropriatecontrolsareinplacetoprovidereasonableassuranceagainstfraudanderror.Duringthe year,
trustees have continued to review risks by updating and refining the Risk Register, which has led to:
```
```
- assessing contract risk
```
```
- further reviewing the Reserves Policy
```
```
- assessing the Investment Policy
```
```
- reviewing safeguards against fraudulent activity by those with access to the charity's bank accounts
```
```
- continuing regular monitoring of income, expenditure, and effective management of the biennial symposia.
```
```
The Risk Register is formally reviewed on an annual basis but financial risks are considered at each meeting.
```
## **`Fraud and Ethics Policy`**
```
FollowingareviewoftheCharityCommission'sbestpracticeguidanceaboutFraud,AntiBriberyandEthics, a
PolicyonthesemattersregardingfraudandethicswasdevelopedandagreedinMarch2017.Itisnoted that
Trusteesand the CompanySecretaryalreadyreceivetrainingand guidanceby virtueof theirprofessionalroles in
the National Health Service.
```
## **`Complaints Policy`**
```
FollowingareviewoftheCharityCommission'sbestpracticeguidance,aComplaintsPolicywasdeveloped and
agreed in March 2019.
```
## **`REFERENCE AND ADMINISTRATIVE DETAILS`**
## **`Registered Company number`**
```
01886866 (England and Wales)
```
## **`Registered Charity number`**
```
291982
```
## **`Registered office`**
```
2 St. Mary's Road
Tonbridge
Kent
TN9 2LB
```
```
Page 7
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2021
```
## **`Trustees`**
```
Dr M J Michell President
Dr A Murphy
Dr P Whelehan Chairman
Ms Z Rees
Ms A Burch
Dr R Given-Wilson
Dr B Dall
Mrs C Borrelli
Dr S Vinnicombe
Dr S Tennant
Dr C Coleman
S E Garnett
Dr M D Halling-Brown
O W E Morrish
S McKellar (appointed 11.1.2021)
D P L Ribet (appointed 11.1.2021)
```
## **`Company Secretary`**
```
Mr A Tillbrook
```
## **`Independent Examiner`**
```
Mr Ryan Cottington
FCCA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
```
ThisreporthasbeenpreparedinaccordancewiththespecialprovisionsofPart15oftheCompaniesAct 2006
relating to small companies.
```
```
Approved by order of the board of trustees on 21 July 2022 and signed on its behalf by:
```
```
Dr P Whelehan - Trustee
```
```
Page 8
```
```
Independent Examiner's Report to the Trustees of
Symposium Mammographicum
```
## **`Independent examiner's report to the trustees of Symposium Mammographicum ('the Company')`**
```
IreporttothecharitytrusteesonmyexaminationoftheaccountsoftheCompanyfortheyear ended
31 December 2021.
```
## **`Responsibilities and basis of report`**
```
Asthecharity'strusteesoftheCompany(andalsoitsdirectorsforthepurposesofcompanylaw)you are
responsibleforthe preparationof the accountsin accordancewiththe requirementsof the CompaniesAct 2006
('the 2006 Act').
```
```
HavingsatisfiedmyselfthattheaccountsoftheCompanyarenotrequiredtobeauditedunderPart16of the
2006Actandareeligibleforindependentexamination,Ireportinrespectofmyexaminationofyour charity's
accountsascarriedoutundersection145oftheCharitiesAct2011('the2011Act').Incarryingout my
examinationI have followedthe Directionsgiven by the CharityCommissionunder section145(5)(b) of the 2011
Act.
```
## **`Independent examiner's statement`**
```
I havecompletedmyexamination.I confirmthatnomattershavecometomyattentioninconnectionwith the
examination giving me cause to believe:
```
`1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or`
`2. the accounts do not accord with those records; or`
`3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or`
`4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).`
```
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which
attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
```
```
Mr Ryan Cottington
FCCA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
```
21 July 2022
```
```
Page 9
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Statement of Financial Activities`**
```
for the Year Ended 31 December 2021
```
|**`2021`**
**`Unrestricted`**
**`funds`**
`Notes`
**`£`**
**`INCOME AND ENDOWMENTS FROM`**
**`Charitable activities`**
`Educational and academic`
**`137,685`**
`Investment income`
`2`
**`362`**
**`Total`**
**`138,047`**
**`EXPENDITURE ON`**
**`Charitable activities`**
`Educational and academic`
**`87,941`**
`Bursaries & awards`
**`500`**
**`Total`**
**`88,441`**
**`NET INCOME/(EXPENDITURE)`**
**`49,606`**
**`RECONCILIATION OF FUNDS`**
**`Total funds brought forward`**
**`93,665`**
**`TOTAL FUNDS CARRIED FORWARD`**
**`143,271`**|`2020`
`Total`
`funds`
`£`
`(4,286)`
`1,001`
`(3,285)`
`11,440`
`-`
`11,440`
`(14,725)`
`108,390`
`93,665`|
|---|---|
```
The notes form part of these financial statements
```
```
Page 10
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Balance Sheet`**
## **`31 December 2021`**
|**`2021`**
**`Unrestricted`**
**`funds`**
`Notes`
**`£`**
**`CURRENT ASSETS`**
`Debtors`
`5`
**`10,998`**
`Cash at bank`
**`140,072`**
**`151,070`**
**`CREDITORS`**
`Amounts falling due within one year`
`6`
**`(7,799)`**
**`NET CURRENT ASSETS`**
**`143,271`**
**`TOTAL ASSETS LESS CURRENT LIABILITIES`**
**`143,271`**
**`NET ASSETS`**
**`143,271`**
**`FUNDS`**
`7`
`Unrestricted funds`
**`143,271`**
**`TOTAL FUNDS`**
**`143,271`**|`2020`
`Total`
`funds`
`£`
`56,321`
`137,429`
`193,750`
`(100,085)`
`93,665`
`93,665`
`93,665`
`93,665`
`93,665`|
|---|---|
```
The charitablecompanyis entitledto exemptionfromaudit under Section477 of the CompaniesAct 2006for the
year ended 31 December 2021.
```
```
Themembershavenotrequiredthecompanytoobtainanauditofitsfinancialstatementsfortheyear ended
31 December 2021 in accordance with Section 476 of the Companies Act 2006.
```
```
The trustees acknowledge their responsibilities for
```
- `(a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and`
- `(b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.`
```
The notes form part of these financial statements
```
```
continued...
```
```
Page 11
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Balance Sheet - continued`**
## **`31 December 2021`**
```
Thesefinancialstatementshavebeenpreparedinaccordancewiththeprovisionsapplicableto charitable
companies subject to the small companies regime.
```
```
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissueon21July2022 and
were signed on its behalf by:
```
```
Dr P Whelehan - Trustee
```
```
The notes form part of these financial statements
```
```
Page 12
```
```
SYMPOSIUM MAMMOGRAPHICUM
```
```
Notes to the Financial Statements
for the Year Ended 31 December 2021
```
## **`1. ACCOUNTING POLICIES`**
## **`Basis of preparing the financial statements`**
```
Thefinancialstatementsofthecharitablecompany,whichisapublicbenefitentityunderFRS102, have
beenpreparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordance with
theFinancialReportingStandardapplicableintheUKandRepublicofIreland(FRS102)(effective 1
January2019)',FinancialReportingStandard102'TheFinancialReportingStandardapplicableinthe UK
and Republicof Ireland'and the CompaniesAct 2006.The financialstatementshavebeen prepared under
the historical cost convention.
```
## **`Income`**
```
AllincomeisrecognisedintheStatementofFinancialActivitiesoncethecharityhasentitlementto the
funds, it is probable that the income will be received and the amount can be measured reliably.
```
## **`Expenditure`**
```
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructiveobligation committing
thecharitytothatexpenditure,itisprobablethatatransferofeconomicbenefitswillberequired in
settlementand the amountof the obligationcan be measuredreliably.Expenditureis accountedfor on an
accrualsbasisandhasbeenclassifiedunderheadingsthataggregateallcostrelatedtothe category.
Wherecostscannotbe directlyattributedtoparticularheadingstheyhavebeenallocatedtoactivities on
a basis consistent with the use of resources.
```
```
Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a
commitment but not accrued as expenditure.
```
## **`Taxation`**
```
The charity is exempt from corporation tax on its charitable activities.
```
## **`2. INVESTMENT INCOME`**
|**`INVESTMENT INCOME`**|||
|---|---|---|
||**`2021`**|`2020`|
||**`£`**|`£`|
|`Deposit account interest`|**`362`**|`1,001`|
```
continued...
```
```
Page 13
```
```
SYMPOSIUM MAMMOGRAPHICUM
```
```
Notes to the Financial Statements - continued
for the Year Ended 31 December 2021
```
## **`3. TRUSTEES' REMUNERATION AND BENEFITS`**
```
Therewere no trustees'remunerationor otherbenefitsfor the year ended 31 December2021nor for the
year ended 31 December 2020.
```
||**`Trustees' expenses`**|||
|---|---|---|---|
|||**`2021`**|`2020`|
|||**`£`**|`£`|
||`Trustees' expenses`|**`1,148`**|`872`|
|**`4.`**|**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`**|||
||||`Unrestricted`|
||||`funds`|
||||`£`|
||**`INCOME AND ENDOWMENTS FROM`**|||
||**`Charitable activities`**|||
||`Educational and academic`||`(4,286)`|
||`Investment income`||`1,001`|
||**`Total`**||`(3,285)`|
||**`EXPENDITURE ON`**|||
||**`Charitable activities`**|||
||`Educational and academic`||`11,440`|
||**`NET INCOME/(EXPENDITURE)`**||`(14,725)`|
||**`RECONCILIATION OF FUNDS`**|||
||**`Total funds brought forward`**||`108,390`|
||**`TOTAL FUNDS CARRIED FORWARD`**||`93,665`|
```
continued...
```
```
Page 14
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Notes to the Financial Statements - continued`**
```
for the Year Ended 31 December 2021
```
## **`5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
|`Trade debtors`
`VAT`
`Prepayments`
**`6.`**
**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
`VAT`
`Other creditors`
`Accruals and deferred income`
**`7.`**
**`MOVEMENT IN FUNDS`**
**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**
`Net movement in funds, included in the above are as follows:`
**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**|`At 1/1/21`
`£`
**`93,665`**
**`93,665`**
`Incoming`
`resources`
`£`
**`138,047`**
**`138,047`**||
|---|---|---|
||||
```
continued...
```
```
Page 15
```
```
SYMPOSIUM MAMMOGRAPHICUM
```
```
Notes to the Financial Statements - continued
for the Year Ended 31 December 2021
```
## **`7. MOVEMENT IN FUNDS - continued`**
## **`Comparatives for movement in funds`**
|**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**
`Comparative net movement in funds, included in the above are a`
**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**|`At 1/1/20`
`£`
`108,390`
`108,390`
`s follows:`
`Incoming`
`resources`
`£`
`(3,285)`
`(3,285)`|`Net`
`movement`
`At`
`in funds`
`31/12/20`
`£`
`£`
`(14,725)`
`93,665`
`(14,725)`
`93,665`
`Resources`
`Movement`
`expended`
`in funds`
`£`
`£`
`(11,440)`
`(14,725)`
`(11,440)`
`(14,725)`|
|---|---|---|
```
A current year 12 months and prior year 12 months combined position is as follows:
```
|||`Net`||
|---|---|---|---|
|||`movement`|`At`|
||`At 1/1/20`|`in funds`|`31/12/21`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`108,390`|`34,881`|`143,271`|
|**`TOTAL FUNDS`**|`108,390`|`34,881`|`143,271`|
```
continued...
```
```
Page 16
```
```
SYMPOSIUM MAMMOGRAPHICUM
```
```
Notes to the Financial Statements - continued
for the Year Ended 31 December 2021
```
## **`7. MOVEMENT IN FUNDS - continued`**
```
Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,includedin the
above are as follows:
```
|**`Unrestricted funds`**
`General fund`
**`TOTAL FUNDS`**|`Incoming`
`resources`
`£`
`134,762`
`134,762`|`Resources`
`Movement`
`expended`
`in funds`
`£`
`£`
`(99,881)`
`34,881`
`(99,881)`
`34,881`|
|---|---|---|
## **`8. RELATED PARTY DISCLOSURES`**
```
There were no related party transactions for the year ended 31 December 2021.
```
```
Page 17
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
```
Detailed Statement of Financial Activities
for the Year Ended 31 December 2021
```
|**`INCOME AND ENDOWMENTS`**
**`Investment income`**
`Deposit account interest`
**`Charitable activities`**
`Delegate sales`
`Sponsorship income`
`Exhibition fees`
**`Total incoming resources`**
**`EXPENDITURE`**
**`Charitable activities`**
`Symposium organisation`
`Symposium costs`
`Grants & awards to individuals`
**`Support costs`**
**`Management`**
`Postage and stationery`
`Advertising`
`Secretarial & administration`
`Travel`
**`Finance`**
`Insurance`
`Sundries`
`Bank charges`|`2021`
`£`
**`362`**
**`76,819`**
**`55,695`**
**`5,171`**
**`137,685`**
**`138,047`**
**`30,124`**
**`40,372`**
**`500`**
**`70,996`**
**`8`**
**`-`**
**`12,480`**
**`(84)`**
**`12,404`**
**`-`**
**`68`**
**`226`**
**`294`**|`2020`
`£`
`1,001`
`(4,286)`
`-`
`-`
`(4,286)`
`(3,285)`
`-`
`(6,253)`
`-`
`(6,253)`
`-`
`594`
`12,646`
`2,001`
`15,241`
`(1,692)`
`35`
`230`
`(1,427)`|
|---|---|---|
```
This page does not form part of the statutory financial statements
```
```
Page 18
```
## **`SYMPOSIUM MAMMOGRAPHICUM`**
## **`Detailed Statement of Financial Activities for the Year Ended 31 December 2021`**
|**`Finance`**
**`Information technology`**
`Domain, website & email hosting`
**`Governance costs`**
`Trustees' expenses`
`Accountancy and legal fees`
`Total resources expended`
**`Net income/(expenditure)`**|`2021`
`£`
**`2,897`**
**`1,148`**
**`702`**
**`1,850`**
**`88,441`**
**`49,606`**|`2020`
`£`
`96`
`872`
`2,911`
`3,783`
`11,440`
`(14,725)`|
|---|---|---|
```
This page does not form part of the statutory financial statements
```
```
Page 19
```